Janssen files patent infringement trial against Samsung Bioepis

Published: 2017-05-23 16:29:00
Updated: 2017-05-23 13:23:45

Janssen, a U.S. global pharmaceutical company, filed a patent infringement trial against Samsung Bioepis.

Janssen recently sued Samsung Bioepis for infringing the 3 patents of ‘Remicade’ with the company’s ‘Renflexis’ at the Superior Court of New Jersey.

‘Renflexis,’ a Samsung Bioepis’s autoimm...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.